Journal Article

476TiPPhase II study of BI1482694 in patients (pts) with T790M-positive non-small cell lung cancer (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)

P.A. Jånne, J. Son, I. Voccia, M. Uttenreuther-Fischer and K. Park

in Annals of Oncology

Published on behalf of European Society for Medical Oncology

Volume 26, issue suppl_9, pages ix145-ix145
Published in print December 2015 | ISSN: 0923-7534
Published online December 2015 | e-ISSN: 1569-8041 | DOI: http://dx.doi.org/10.1093/annonc/mdv532.60
476TiPPhase II study of BI1482694 in patients (pts) with T790M-positive non-small cell lung cancer (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)

Show Summary Details

Journal Article.  363 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.